We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

8 hedge funds and large institutions have $534K invested in China Pharma Holdings in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more funds holding

Funds holding: 5 → 8 (+3)

16% more capital invested

Capital invested by funds: $460K → $534K (+$74K)

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
8
Holders Change
+3
Holders Change %
+60%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
Virtu Financial
New York
+$31.6K
2
Renaissance Technologies
Renaissance Technologies
New York
+$28.2K
3
TSS
Two Sigma Securities
New York
+$14.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.02K

Top Sellers

1
HF
HRT Financial
New York
-$56.7K
2
Citadel Advisors
Citadel Advisors
Florida
-$37.2K
3
UBS Group
UBS Group
Switzerland
-$12.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$354K +$28.2K +131 +9%
BCM
2
Bridgeway Capital Management
Texas
$105K – – –
VF
3
Virtu Financial
New York
$33K +$31.6K +147 New
TSS
4
Two Sigma Securities
New York
$15K +$14.8K +69 New
HF
5
HRT Financial
New York
$8K -$56.7K -264 -88%
UBS Group
6
UBS Group
Switzerland
$8K -$12.5K -58 -60%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$6K +$6.02K +28 New
Citadel Advisors
8
Citadel Advisors
Florida
$5K -$37.2K -173 -88%

CPHI Hedge Fund Activity: Q4 2020 in Review

8 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2020, worth a combined $534K — up 16% from $460K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPHI positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $31.6K. The largest seller was HRT Financial, cutting an estimated $56.7K.

  • 8 institutional investors held China Pharma Holdings (CPHI) as of Q4 2020, up from 5 in Q3 2020.
  • Funds reported $534K of China Pharma Holdings stock for Q4 2020, up 16% quarter-over-quarter.
  • 3 funds opened new China Pharma Holdings positions in Q4 2020 and 0 closed out, a net change of +3 holders.
  • The largest China Pharma Holdings buyer in Q4 2020 was Virtu Financial, an estimated $31.6K added.
  • The largest China Pharma Holdings seller in Q4 2020 was HRT Financial, an estimated $56.7K sold.

Based on aggregated 13F filings for Q4 2020.